Inhaled Corticosteroids Should Not Be Prescribed to All Chronic Obstructive Pulmonary Disease Patients

Inhaled Corticosteroids Should Not Be Prescribed to All Chronic Obstructive Pulmonary Disease Patients

Saved in:

Bibliographic Details
Main Authors:	Jean Bourbeau, Andrew McIvor
Format:	Article
Language:	English
Published:	Wiley 2003-01-01
Series:	Canadian Respiratory Journal
Online Access:	http://dx.doi.org/10.1155/2003/495751
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
by: Elvis M. Irusen, et al.
Published: (2020-12-01)

Meta-Analysis Should Not Be Simply Conducted By Default: Biologic Therapy for Chronic Obstructive Pulmonary Disease
by: Jean Bourbeau, et al.
Published: (2025-05-01)

Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect?
by: Srishankar Bairy, et al.
Published: (2025-01-01)

Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review
by: Roger Knaggs, et al.
Published: (2020-04-01)

Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-12-01)

Mortality among Subjects with Chronic Obstructive Pulmonary Disease or Asthma at Two Respiratory Disease Clinics in Ontario
by: Murray M Finkelstein, et al.
Published: (2011-01-01)

Inhaled Steroids in Chronic Obstructive Pulmonary Disease
by: Nick R Anthonisen
Published: (2002-01-01)

Effect of long-term inhaled corticosteroids therapy on cognitive function in patients with bronchial asthma and chronic obstructive pulmonary disease
by: Swapnil N. Deshmukh, et al.
Published: (2025-03-01)

Dose of Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease and Risks of Osteoporosis or Fracture—A Systematic Review and Meta‐Analysis
by: Wang Chun Kwok, et al.
Published: (2025-05-01)

Risk of Cardiovascular Events Associated with Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis
by: Xia Jing, et al.
Published: (2018-01-01)

Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment
by: Lucie Blais, et al.
Published: (2004-01-01)

Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada
by: Nguyen Xuan Thanh, et al.
Published: (2019-01-01)

Corrigendum to “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada”
by: Nguyen Xuan Thanh, et al.
Published: (2019-01-01)

Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Fathur Nur Kholis, et al.
Published: (2023-01-01)

Optimizing the Delivery of Inhaled Medication for Respiratory Patients: The Role of Valved Holding Chambers
by: R. Andrew McIvor, et al.
Published: (2018-01-01)

Real-World Outcomes of Single-Inhaler Triple Therapy Prescribed by General Practitioners in Managing Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
by: Linet Odonde, et al.
Published: (2025-02-01)

The Nurse Practitioners’ Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease
by: Jane Scullion
Published: (2018-01-01)

Oral Corticosteroid Use and the Risk of Acute Myocardial Infarction in Chronic Obstructive Pulmonary Disease
by: Laetitia Huiart, et al.
Published: (2006-01-01)

Obesity and Chronic Obstructive Pulmonary Disease: Is Fatter Really Better?
by: Roxana G Galesanu, et al.
Published: (2014-01-01)

Comparative efficacy of leukotriene modifier and inhaled corticosteroids in the complex treatment of steroid-naive patients with bronchial asthma combined with chronic obstructive pulmonary disease with neutrophilic type of inflammation
by: Yu. I. Feshchenko, et al.
Published: (2021-07-01)

Should all patients with COPD be treated with inhaled triple therapy?
by: Don D. Sin, et al.
Published: (2025-04-01)

Improving the Inhalation Technique in Patients with Obstructive Pulmonary Diseases
by: Zlatina Ivanova, et al.
Published: (2016-12-01)

Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
by: Jennifer K Quint, et al.
Published: (2020-09-01)

Minimising inhaled corticosteroids for COPD
by: Benji Heran, et al.
Published: (2024-12-01)

French-Canadian Version of the Chronic Respiratory and of the St George's Respiratory Questionnaires: An Assessment of their Psychometric Properties in Patients with Chronic Obstructive Pulmonary Disease
by: Jean Bourbeau, et al.
Published: (2004-01-01)

Effects of Inhaled Fenoterol and Positive End-Expiratory Pressure on the Respiratory Mechanics of Patients with Chronic Obstructive Pulmonary Disease
by: Claude Guerin, et al.
Published: (2005-01-01)

Knowledge, attitudes, and practices of inhalation device use among patients with chronic obstructive pulmonary disease
by: Yadan Tu, et al.
Published: (2025-07-01)

Evaluation of symptom control in chronic obstructive pulmonary disease after reinforcement of proper inhaler technique
by: Tanya Jaiswal, et al.
Published: (2025-07-01)

Number 5: Inhaled Corticosteroids in Asthma
by: Richard Leigh
Published: (2001-01-01)

Retracted: A Novel Curcumin-Based Drug Powder Inhalation Medicine for Chronic Obstructive Pulmonary Disease
by: Bioinorganic Chemistry and Applications
Published: (2023-01-01)

Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease
by: Gert T. Verhoeven, et al.
Published: (2001-01-01)

Effect of Gamification on Improved Adherence to Inhaled Medications in Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial
by: Xiting Huang, et al.
Published: (2025-05-01)

Tobacco Control and Nicotine Addiction in Canada: Current trends, Management and Challenges
by: Andrew McIvor
Published: (2009-01-01)

Inhaled Triple Therapy with Extrafine Single Inhaler Versus Multiple Devices in Chronic Obstructive Pulmonary Disease (TRIPOLI): A Post-Authorization Retrospective Study
by: Cabrera César E, et al.
Published: (2025-05-01)

Evaluation of Inhaler Technique in Patients with Asthma and Chronic Obstructive Pulmonary Disease in Andaman and Nicobar Islands – An Observational Study
by: M. Natraj, et al.
Published: (2025-01-01)

Predictors of treatment REsponse to inhaled corticosteroids (ICS) in Chronic Obstructive pulmonary disease: randomised controlled trials individual participant Data re-Evaluation–protocol of the ICS-RECODE individual participant data meta-analysis
by: Matthew Sperrin, et al.
Published: (2025-03-01)

Canadian Practice Assessment in Chronic Obstructive Pulmonary Disease: Respiratory Specialist Physician Perception Versus Patient Reality
by: Paul Hernandez, et al.
Published: (2013-01-01)

Comparative adherence and persistence of single-inhaler and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in Japan: a retrospective cohort study
by: Olivia Massey, et al.
Published: (2024-12-01)

Impact of patient compliance with inhaler therapy on chronic obstructive pulmonary disease severity: a rural tertiary care perspective
by: Nandakishore K. S., et al.
Published: (2025-02-01)

Addressing inhaler technique challenges in cognitively impaired chronic obstructive pulmonary disease patients: the impact of customized training programs
by: Vaishnavi V Gaonkar, et al.
Published: (2025-01-01)